Although the effectiveness of influenza vaccination is confirmed by RCTs, the Policy Appraisal Act encourages objective appraisal of any ongoing programs particularly those involving personal risks and costs. However, RCTs are not feasible in the practical setting and even unethical given the proven effectiveness of vaccination. Therefore an alternative method to RCT for appraisal of the effectiveness of vaccination using readily accessible data is needed.
Health insurance claims (claims) are the most accessible individual-level data for municipal governments that operate the National Health Insurance program in monitoring patients' behaviors.
The author proposes using the claims for evaluation of the effectiveness of influenza vaccination.
Methods

Ethical consideration
The study was conducted pursuant to the Natori city ordinance on "Survey on influenza vaccination" as well as the city Privacy Protection Ordinance.
Informed consent was not obtained at the time of vaccination because this study was proposed after the influenza season was over. The waiver of informed consent was then authorized by the Ethics Review Committee of NIPH2) pursuant to the Ethical Guidelines for Epidemiological Research, which states, "Observational studies that do not involve human specimens do not necessarily require individual informed consent on the condition that the public is well informed of the ongoing study". To comply with this condition, the initiation of the study was published on the city newsletter as well as in the city website.
. Measures taken for privacy protection
Outpatient health insurance claims of the NHI program of Natori City were input into Excel files by the Miyagi Federation of National Health Insurance (MFNHI) , which is authorized by the NHI Act to review and process health insurance claims. The input data were name, sex, age, household ID, providers ID, number of days, total cost (in points) and diagnoses (recorded in ICD10 coding plus 40 additional categories including "influenza" up to 15 diagnoses, beyond which were omitted) .
The computer file was manually matched with the list of influenza vaccination recipients who had been vaccinated in October 2001 through January of 2002 by city staff of the municipal health center of the city, who input a distinct mark "1" in vaccine recipients. The file was partially deleted with name and household ID and was replaced with serial number. The file was then provided to the author for analysis thereby concealing the individual patients' identity.
. Theory and design
The design of this study is retrospective observational study comparing the number of outpatient days of influenza between vaccinated and non-vaccinated groups. To overcome the limitations of the retrospective and observational study design, two methodologies were adopted : objective measurement of influenzarelated outpatient days and comparison by relative share of influenza-related outpatient days against total outpatient days instead of comparing outpatient days per capita.
The rationale of using relative share of outpatient days is the assumption that the "risk" of the group, which shall be adjusted by randomization in the case of RCTs, is reflected in outpatient visits, i.e., high-risk elderly shall have higher outpatient visits than low-risk elderly. The next assumption is that vaccination will affect only influenza (and related respiratory diseases) leaving other diseases unaffected as illustrated in Figure 1 . If vaccine has any effect, it will manifest as reduction of % of influenza in outpatient visits in the same way in both high-and low-risk elderly, which can be viewed as the effect of vaccination. 4 Data and validity Health insurance claims are by no means medical certificates and validity of diagnoses recorded in them is not without question nor do they certify the cause and relationship with the disease in question.
However, the author believes that the relative lack of validity will not pose significant hindrance because it is unlikely that such lack of validity will affect one group alone. If such a lack of validity exists, it will affect both vaccinated and nonvaccinated groups equally, not unilaterally. As long as validity holds constant in both groups, comparison between them will still make sense as an estimation of the difference of outpatient visits.
Although days recorded in health insurance claims do not exactly match with the number of outpatient visits (for example, two visits in a Table  1 Basic data of Natori vaccination program and claims day will be counted as one day in health insurance claims), the number of days was used as proxy of outpatient visits for this analysis. The outline of the analyzed data is presented in Table 1 . 5 . Outcome measurement Health insurance claims are characterized by multiple diagnoses (on average 4.27-4.28 diagnoses per claim). Influenza-related outpatient days plus outpatient days for other respiratory diseases were estimated using an objective method.
Claims of vaccinated and nonvaccinated groups were analyzed by PDM (Proportional Disease Magnitude) method, which distributes cost and days of claims in proportion to the pre-assigned "magnitude" of each diagnosis3). In this study, the arithmetic mean of outpatient days per claim was used as magnitude.
The estimated disease-specific outpatient days for influenza were then divided by the total outpatient days to be converted into the share of influenza in outpatient days. Comparison was made using the share between vaccinated and non-vaccinated groups.
Results
Out of 10,530 elderly, 3,214 or approximately 30% were vaccinated. The vaccinated group is characterized by a higher institutionalized rate (196 out of 3,214 or 6.1% as opposed to 4 out 7,316 or 0.05% of the non-vaccinated group) (Table 1) . However, the incidence of influenza cannot be calculated from this because not all elderly are enrolled to the city National Health Insurance program (enrollment is 76%).
A total 9,891 claims of elderly patients were matched with the list of vaccination and were separated into 3,214 claims from the vaccinated group and 7,316 claims from the nonvaccinated group. The basic data of the two data sets are presented in Table 1 as well. It is noteworthy that the average age of the vaccinated group is 1.8 years older than the nonvaccinated group reflecting a higher institutionalized rate. The estimated share of influenza and other respiratory diseases between both vaccinated and non-vaccinated groups is summarized in Table 2 . Influenza accounted for 0.319% of Table 2 Comparison between vaccinated and non-vaccinated groups total outpatient days of the non-vaccinated group while 0.053% of the vaccinated group, the difference (0.266%) of which was statistically significant (95% CI: 0.106%-0.426%) . In other words, the vaccinated group visited doctors 83.4% less often in relation to the total number of visits for influenza despite higher risks (higher age and institutionalized rate) than the non-vaccinated group. For other respiratory diseases, the vaccinated group utilized approximately half of the outpatient days for the category of "other respiratory diseases (includes pneumonia and bronchitis caused by influenza) " whose difference was statistically significant (0.236% vs.
0.476%, 95% CI of the difference : 0.007%-0.473%) . Vaccinated groups also showed less utilization of outpatient visits for "pneumonia", "acute bronchitis" , "acute nasopharyngitis [common cold] and "asthma" than the nonvaccinated group, although none of them were significant.
However, the vaccinated group showed a higher share of outpatient days for "acute tonsilitis" and "chronic obstructive pulmonary diseases (COPD) " than the non-vaccinated group, although none of them were statistically significant. When all acute respiratory diseases were combined (i.e, excluding COPD) , the vaccinated group utilized 20% less outpatient days than the vaccinated group (4.037% vs. 5.059% of total days, 95% CI of the difference : 0.181%-1.863%) .
Discussions
The U. S. CDC (Center for Disease Control) estimates the effectiveness of influenza vaccination for the general population younger than 65 in controlling onsets at 80%4). Also the research project sponsored by the Ministry of Health, Labor & Welfare reported that influenza vaccination for elderly reduces influenzarelated mortality by 82%. Although the outcome measure is not the same, the estimated reduction of outpatient visits of vaccinated group (83.4%) turned out to be consistent with the ones estimated by the preceding studies.
Smaller epidemic size of influenza during the surveyed season than usual years reduced the power of estimate, but the effect size of the vaccine and sample size of claims could barely achieve confidence level of 5% and power of 80% according to a sensitivity analysis5).
Given the limitations of a retrospective observational study, the cause-effect relationship could not be established. It can easily be concluded that patients with COPD were more likely to receive vaccination for fear of exacerbation, not that vaccine caused COPD, because COPD is not the kind of disease to develop in a short time, as adverse effects. However the higher outpatient days for acute tonsilitis observed in the vaccinated group is confusing : it cannot be ruled out that vaccine causes acute tonsilitis as its adverse effects and hence warrants further monitoring.
With all these limitations, it would still be safe to conclude that the vaccinated communitydwelling elderly utilized less outpatient days for influenza and other respiratory diseases despite their higher risks than the non-vaccinated counterparts. 
